|
|
|
|
| |
TAKE THIS POLL |
|
|
- Alnylam to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference 5 Sep 2008 23:11 GMT
... most advanced program is in Phase II human clinical trials for the treatment of respiratory syncytial virus (RSV) infection. In addition, the company is developing RNAi therapeutics for the treatment of ...
- Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center N 4 Sep 2008 14:14 GMT
... focus of the SRSBSC team is on virology, our infrastructure would support the screening of ... B and C, herpes, HIV, influenza, and respiratory syncytial viruses. Of these, almost half are for ...
- Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe 4 Sep 2008 14:12 GMT
... focus of the SRSBSC team is on virology, our infrastructure would support the screening of ... B and C, herpes, HIV, influenza, and respiratory syncytial viruses. Of these, almost half are for ...
- Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4 Sep 2008 14:10 GMT
... focus of the SRSBSC team is on virology, our infrastructure would support the screening of ... B and C, herpes, HIV, influenza, and respiratory syncytial viruses. Of these, almost half are for ...
- Isis Receives Notices of Allowance That Significantly Expand the Scope of Key RNA Therapeutic Patents 4 Sep 2008 13:32 GMT
... most advanced program is in Phase II human clinical trials for the treatment of respiratory syncytial virus (RSV) infection. In addition, the company is developing RNAi therapeutics for the treatment of ...
1 - 6 of 6
News by PR Newswire
|
| Tip of the day
Related Newsletters
Come and Visit
|
|
| | |